Bicara Therapeutics Inc. ( (BCAX) ) has released its Q3 earnings. Here is a breakdown of the information Bicara Therapeutics Inc. presented to ...

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, ...

Perspective Therapeutics, Inc. ( (CATX) ) has released its Q3 earnings. Here is a breakdown of the information Perspective Therapeutics, Inc.

On Tuesday, Tango Therapeutics Inc (TNGX) stock saw a decline, ending the day at $3.35 which represents a decrease of $-0.03 or -0.89% from the prior close of $3.38. The stock opened at $3.48 and ...

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good morning, and welcome to the Axsome Therapeutics Third ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Thank you for standing by and welcome to Heron Therapeutics ...

Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...

CHAPEL HILL, N.C. (AP) — CHAPEL HILL, N.C. (AP) — Tenax Therapeutics Inc. (TENX) on Wednesday reported a loss of $4 million in its third quarter. On a per-share basis, the Chapel Hill, North ...

SEATTLE (AP) — SEATTLE (AP) — Perspective Therapeutics, Inc. (CATX) on Tuesday reported a loss of $15.1 million in its third quarter. On a per-share basis, the Seattle-based company said it had a loss ...